Jeff Yass’s Annovis Bio ANVS Stock Holding History

Jeff Yass’s Portfolio ANVS Stock Details ANVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$241K	Buy	129,700 +30,300	+30%	+$58.9K	﹤0.01%	11551
2026 Q1	$222K	Buy	99,400 +21,400	+27%	+$58.7K	﹤0.01%	11496
2025 Q4	$270K	Buy	78,000 +32,000	+70%	+$96.2K	﹤0.01%	10204
2025 Q3	$95.2K	Sell	46,000 -5,800	-11%	-$14.5K	﹤0.01%	11596
2025 Q2	$112K	Sell	51,800 -21,900	-30%	-$43.2K	﹤0.01%	11714
2025 Q1	$111K	Sell	73,700 -113,700	-61%	-$348K	﹤0.01%	11476
2024 Q4	$943K	Buy	187,400 +56,800	+43%	+$411K	﹤0.01%	7114
2024 Q3	$1.05M	Sell	130,600 -201,700	-61%	-$1.89M	﹤0.01%	6679
2024 Q2	$1.91M	Buy	332,300 +199,300	+150%	+$1.62M	﹤0.01%	5193
2024 Q1	$1.58M	Buy	+133,000	New	+$1.45M	﹤0.01%	5879

Other funds holding ANVS

EAM

Empery Asset Management New York $86.5M AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Jeff Yass's ANVS Position: Q2 2026 in Review

Jeff Yass reduced its Annovis Bio (ANVS) stake by 33% in Q2 2026, selling an estimated $139K and leaving 146,804 shares worth $273K. The position accounts for ﹤0.01% of the portfolio, ranked #11263.

Jeff Yass first reported a position in ANVS in Q1 2023 and has held it in 11 quarters since. The position peaked at $1.05M in Q4 2025. 61 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

Jeff Yass held 146,804 shares of Annovis Bio worth $273K as of Q2 2026.
Jeff Yass sold 71,532 Annovis Bio shares in Q2 2026, an estimated $139K.
Annovis Bio made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #11263 holding.
Jeff Yass first reported a position in Annovis Bio in Q1 2023 and has held it in 11 quarters since.
Jeff Yass's Annovis Bio position peaked at $1.05M in Q4 2025.
61 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.